Minimally invasive thymectomy for myasthenia gravis favours left-sided approach and low severity class.

Complete stable remission Laterality approach Myasthenia Gravis Foundation of America Myasthenia gravis Pharmacological remission Robotic thymectomy Video-assisted thoracic surgery thymectomy

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
22 10 2021
Historique:
received: 13 05 2020
revised: 02 12 2020
accepted: 08 12 2020
pubmed: 5 2 2021
medline: 11 11 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

Complete thymectomy is a key component of the optimal treatment for myasthenia gravis. Unilateral, minimally invasive approaches are increasingly utilized with debate about the optimal laterality approach. A right-sided approach has a wider field of view, while a left-sided approach accesses potentially more thymic tissue. We aimed to assess the impact of laterality on perioperative and medium-term outcomes, and to identify predictors of a 'good outcome' using standard definitions. We performed a multicentre review of 123 patients who underwent a minimally invasive thymectomy for myasthenia gravis between January 2000 and August 2015, with at least 1-year follow-up. The Myasthenia Gravis Foundation of America standards were followed. A 'good outcome' was defined by complete stable remission/pharmacological remission/minimal manifestations 0, and a 'poor outcome' by minimal manifestations 1-3. Univariate and multivariable logistic regression analyses were performed to assess factors associated with a 'good outcome'. Ninety-two percent of thymectomies (113/123) were robotic-assisted. The left-sided approach had a shorter median operating time than a right-sided: 143 (interquartile range, IQR 110-196) vs 184 (IQR 133-228) min, P = 0.012. At a median of 44 (IQR 27-75) months, the left-sided approach achieved a 'good outcome' (46%, 31/68) more frequently than the right-sided (22%, 12/55); P = 0.011. Multivariable analysis identified a left-sided approach and Myasthenia Gravis Foundation of America class I/II to be associated with a 'good outcome'. A left-sided thymectomy may be preferred over a right-sided approach in patients with myasthenia gravis given the shorter operating times and potential for superior medium-term symptomatic outcomes. A lower severity class is also associated with a 'good outcome'.

Identifiants

pubmed: 33538299
pii: 6128454
doi: 10.1093/ejcts/ezab014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

898-905

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Candice L Wilshire (CL)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Sandra L Blitz (SL)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Carson C Fuller (CC)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Jens C Rückert (JC)

Department of Thoracic Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Feng Li (F)

Department of Thoracic Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Robert J Cerfolio (RJ)

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, NY, USA.

Asem F Ghanim (AF)

Department of Thoracic Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.

Mark W Onaitis (MW)

Department of Thoracic Surgery, University of California San Diego, San Diego, CA, USA.

Inderpal S Sarkaria (IS)

Department of Thoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Dennis A Wigle (DA)

Department of Thoracic Surgery, Mayo Clinic, Rochester, MN, USA.

Vijay Joshi (V)

Department of Thoracic Surgery, Mayo Clinic, Rochester, MN, USA.

Scott Reznik (S)

Department of Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Adam J Bograd (AJ)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Eric Vallières (E)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Brian E Louie (BE)

Department of Thoracic Surgery, Swedish Cancer Institute, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH